ACAT-IN-9 is an acyl-Coenzyme A:cholesterol acyltransferase (ACAT) inhibitor extracted from patent EP1236468A1, example 207. ACAT-IN-9 inhibits NF-κB mediated transcription.

Product information

CAS Number: 199984-40-2

Molecular Weight: 601.84

Formula: C33H51N3O5S

Chemical Name: 2-amino-N-[3, 5-bis(propan-2-yl)-4-[({2-[2, 4, 6-tris(propan-2-yl)phenyl]acetamido}sulfonyl)oxy]phenyl]-2-methylpropanamide

Smiles: CC(C)(N)C(=O)NC1=CC(C(C)C)=C(OS(=O)(=O)NC(=O)CC2C(=CC(=CC=2C(C)C)C(C)C)C(C)C)C(=C1)C(C)C

InChiKey: QEUSGTLPGVCJRU-UHFFFAOYSA-N

InChi: InChI=1S/C33H51N3O5S/c1-18(2)23-13-25(19(3)4)29(26(14-23)20(5)6)17-30(37)36-42(39,40)41-31-27(21(7)8)15-24(16-28(31)22(9)10)35-32(38)33(11,12)34/h13-16,18-22H,17,34H2,1-12H3,(H,35,38)(H,36,37)

Technical Data

Appearance: Solid Power

Purity: ≥98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis

Storage Condition: Dry, dark and -20 ^oC for 1 year or refer to the Certificate of Analysis.

Shelf Life: ≥12 months if stored properly.

Stock Solution Storage: 0 - 4 ^oC for 1 month or refer to the Certificate of Analysis.

Drug Formulation: To be determined

HS Tariff Code: 382200

Products are for research use only. Not for human use.